The Children’s Tumor Foundation

Healx, established in 2014 and headquartered in Cambridge, UK, is a biotechnology company specializing in rare disease treatments. It employs artificial intelligence and machine learning to identify and repurpose existing drugs for new therapeutic uses, aiming to accelerate drug discovery and reduce development risks. By integrating deep pharmacology expertise and patient engagement, Healx matches treatments to disease patients, addressing unmet needs in the rare disease space.